Intraoperational Prostate Loge Biopsies (iPROLOGX) After Radical Prostatovesiculectomy (iPROLOGX)
Prostate Cancer
About this trial
This is an interventional basic science trial for Prostate Cancer focused on measuring Prostate Cancer, Molecular staging, GSTP1, Surgical margins, prostatovesiculectomy
Eligibility Criteria
Criteria for patients with prostate adenocarcinoma:
Inclusion Criteria
- sex: male
- diagnosis: prostate adenocarcinoma
- treatment: radical prostatovesiculectomy
- period of treatment: 11/30/2011 - 10/15/2013
Exclusion Criteria
- sex: female
- diagnosis: no prostate adenocarcinoma
- treatment: no radical prostatovesiculectomy
- period of treament: before 11/30/2011 or after 10/15/2013
Criteria for prostate adenocarcinoma negative control group:
Inclusion Criteria
- sex: male
- diagnosis: urothelial carcinoma
- treatment: cysto-prostatectomy
- period of treament: 12/14/2011 - 02/18/2014
Exclusion Criteria
- sex: female
- diagnosis: incidental prostate adenocarcinoma
- treatment: no cysto-prostatectomy
- period of treatment: before 12/14/2011 or after 02/18/2014
Sites / Locations
- St. Antonius Hospital
- Department of Urology, University Clinic Otto von Guericke University Magdeburg
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Active Comparator
Active Comparator
PCA Magdeburg
Non-prostate cancer Magdeburg/Gronau
PCA Gronau
Prostate cancer conducted for RPVE with curative Intention, biopsies of the prostatic fossa in Magdeburg
Conducted for CE in Male with bladder cancer or other indication for cystectomy but without prostate cancer in Magdeburg or Gronau, biopsies of the prostatic fossa in Gronau
Prostate cancer conducted for ETRARP with curative Intention, biopsies of the prostatic fossa